Alkaline Peptides | FOX04-DRI 25mg

FOXO4-DRI is a synthetic peptide designed as a selective inhibitor of the FOXO4–p53 interaction. It has been studied for its role in cellular senescence, where it is examined for its ability to influence aging processes and tissue health.

Research on FOXO4-DRI often focuses on its mechanism of disrupting the binding of FOXO4 to p53, a pathway that regulates the survival of senescent cells. By interfering with this interaction, FOXO4-DRI has been investigated for its potential to promote the clearance of dysfunctional cells and restore healthy tissue function.

Because of its targeted activity, FOXO4-DRI is also explored in the context of age-related research, regenerative medicine, and cellular stress responses. These properties have made it an important subject for ongoing studies in molecular biology and longevity science.

Amino Acid Profile

Peptide Sequence: D-Arg-Aib-Phe-D-Phe-Leu

DISCLAIMER:

This product has not been evaluated by the FDA and is solely for research only. It is not intended to diagnose, treat, cure, or prevent any diseases, illnesses, or medical conditions. For any specific advice or recommendations, please consult with healthcare professional.

Our customer service team and chat support are available to answer general questions about your order or provide general information about our products. However, we cannot offer any form of consultation.